Skip to main content
. 2019 Jan 29;17(3):2359–2365. doi: 10.3892/etm.2019.7213

Figure 1.

Figure 1.

miR-212 and HIF-1α mRNA expression levels in samples from patients with PDAC and the association with prognosis. (A) Expression analysis of miR-212 and HIF-1α mRNA levels in PDAC samples and adjacent normal pancreatic samples determined by a reverse transcription-quantitative polymerase chain reaction. (B) Association between HIF-1α expression levels and the overall survival time of patients with PDAC. (C) Association between miR-212 expression levels and the overall survival of patients with PDAC. P<0.05 was determined using the log-rank test. *P<0.05. miR, microRNA; HIF-1α, hypoxia-inducible factor-1α; PDAC, pancreatic ductal adenocarcinoma; (−), negative expression (<25%); (+), low expression (26–50%); (++) medium expression (51–75%); (+++) high expression (>76%).